Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
An animal model is the non-human species which is used commonly in medical research because it can mimic aspects of a disease which are found in humans. Animal models are used to obtain information about a disease and its prevention, diagnosis and treatment. Scientists use animal to learn more about health problems which affects humans as well as animals and to ensure the safety of new medical treatments. Animals are needed for development of drugs and medical procedures for treatment of diseases.
The Europe animal model market is observing rapid growth during forecast period of 2021 to 2027. The animal model have been used for addressing various scientific questions from basic science to the development and assessment of novel vaccines or therapies. The key factors such as surge in usage of animal models in pre-clinical development is propelling growth of Europe animal model market. The increase in pipeline of pharmaceutical and biopharmaceutical companies is also boosting growth of Europe animal model market. However, growing opposition on animal testing by several organizations is hindering the growth of Europe animal model market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the animal model market. In addition, complete analysis of changes on animal model expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Europe economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The rising incidences of various diseases and viral infections such as COVID-19 increases the demand for animal models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of animal model market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of animal model market during COVID-19 period.
The Europe animal model market is categorised into animal type, application, end user and country.
Based on animal type, the Europe animal model market is segmented into the pigs, cats, mice, monkey, rabbit and other animals such as dog. In which monkey is also contributing to the growth of Europe animal model market. The researcher considered the gene insertion in the monkey which will lead to monkey models of human diseases such as alzheimer’s disease, diabetes, heart diseases and obesity which offers the more robust testing ground for novel drugs, gene therapy and modified stem cells. This makes them more demandable in the market.
Based on application, the Europe animal model market is bifurcated into the research and development and production and quality control. The research and development segment is estimated to dominate the market in 2020. The growing research and development activities in pharmaceutical industries is propelling growth of Europe animal model market. The rising exigency for quality testing of pharmaceuticals is also driving growth of Europe animal model market. The rising development novel medicines is also refuelling growth of Europe animal model market.
Based on end user, the Europe animal model market is categorised into the research institute, pharmaceutical companies, contract research organizations and educational institutes. In which contract research organizations is also contributing to the growth of the Europe animal model market. The rising outsourcing of pharmaceuticals is propelling growth of Europe animal model market. The growing cases of chronic diseases is also boosting growth of Europe animal model market. The rising drug safety regulations is also driving growth of Europe animal model market.
The Europe animal model market is studied for key countries such as United Kingdom, Germany, France, Italy and Spain. In which United Kingdom is anticipated to dominate the market in 2020. The rising research and development activities in healthcare industry is propelling growth of Europe animal model market. The rising need for drug safety data is also boosting growth of Europe animal model market. The rising demand for vaccine development is also boosting growth of Europe animal model market.
The key players comprised in animal model market are Janvier Labs, Charles River Laboratories, Genoway S.A., Envigo, Taconic Laboratories, Transgenic Inc., Sage Labs, Horizon Discovery, Crown Bioscience Inc. and Harbor Antibodies Bv (A Subsidiary Of Harbor Biomed) among others.
Apr 2021: Horizon Discovery is shared that IGM Biosciences, a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies has signed a multi-license commercial agreement within two years of their first license for the continued use of the Horizons cGMP-compliant CHO SOURCE platform for further development of IGM’s novel therapeutic IgM antibodies.
January 2020: Horizon Discovery Group plc (Horizon or the Group), a global leader in the application of gene editing and gene modulation technologies, has announced the collaboration and license agreement with Mammoth Biosciences (Mammoth or the Company), for access of Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics such as therapeutic antibodies.
December 2019: Horizon Discovery Group plc (Horizon), a global leader in the application of gene editing and gene modulation for cell line engineering, announced their partnership with The Human Protein Atlas (HPA). HPA has selected Horizon’s CRISPR-edited knockout cell models to further expand the knowledge available in its Cell Atlas program, to advance our understanding of the genetic drivers of disease.
September 2019: Horizon Discovery Group plc (Horizon), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the full commercial licensing to Glen Mark Pharmaceuticals, a global innovative pharmaceutical company, for its gene-edited Glutamine Synthetizes (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line. Terms of the agreement were based on stringent evaluation of the cell line by Glen mark to assess its suitability for adoption into the Company’s biomanufacturing processes.
March 2019: Horizon Discovery Group plc (Horizon), a global leader in gene editing and gene modulation technologies, announced their collaboration with St George’s University Hospital, London, and the European Molecular Genetics Quality Network (EMQN), based within the Manchester Centre for Genomic Medicine at Saint Mary’s Hospital, to develop reference material for non-invasive prenatal testing (NIPT).
The report analyses the animal model market based on animal type, application, end user and country. The various types of animals covered in the report are pigs, cats, mice, monkey, rabbit and other animal such as dog. By application, the market is segmented into research and development and production and quality control. Based on end user, the market is segmented into research institutes, pharmaceutical companies, contract research organizations and educational institutes. The report also covered the impact of COVID-19 on the animal model market and it is found that the rising incidences of various diseases and viral infections such as COVID-19 increases the demand for animal models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of animal model market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of animal model market during COVID-19 period. The report also covers the major key players operating in the market.
Why to buy this report
